Company intelligence / Profile preview

CeraVx

Ownership: Private
Development stage: Preclinical

Overview

CeraVx has developed a proprietary ceramic microneedle patch platform ("CeraMaps") designed for minimally invasive, pain-free intradermal delivery of vaccines and therapeutics. The technology enables efficient immune response with lower doses compared to traditional injection methods. Clinical results are not yet published but the company is active in preclinical/early clinical development with proven expertise in research collaborations.

Therapeutic areas: OtherDermatologyInfectious Diseases
Modalities: Microneedle array patches for drug and vaccine deliverySmall molecules, biologicals, nanoparticles (as compatible payloads)
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

CeraPore

Pre-clinical

Indications: Vaccine delivery

1 more asset in the full pipeline.

Request access →

Partnerships

Open to partnerships with biopharma companies and research centers for R&D, clinical trials, diagnostics development.

Beyond the preview

Go deeper on CeraVx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CeraVx.

Explore the full profile